David C Dale, University of Washington, Seattle, Washington, USA
Published online: September 2008
DOI: 10.1002/9780470015902.a0002179.pub2
Neutropenia is a decrease in the number of neutrophilic leucocytes in the blood. Clinically neutropenia is defined as an absolute blood neutrophil count (total white blood cells per litre multiplied by the percentage of neutrophils) more than two standard deviations below the normal mean.
Keywords: neutrophil; neutropenia; chemotherapy-induced neutropenia; idiosyncratic drug-induced neutropenia; autoimmune neutropenia; severe chronic neutropenia
| References | |
| Crawford J, Althaus B, Armitage J et al. (2007) Myeloid growth factors. Clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network 5: 188–202. | |
| Dale DC, Person RE, Bolyard AA et al. (2000) Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood 96: 2317–2322. | |
| book Dale DC (2006) "Neutropenia and Neutrophilia". In: Lichtman MA, Kipps TJ, Kaushansky K et al. (eds) William's Hematology, 7th edn, 907–919. New York, NY: McGraw-Hill. | |
| Freifeld AG, Sepkowitz KA, Martino P et al. (2006) Antibacterial prophylaxis in patients with cancer and neutropenia. New England Journal of Medicine 354: 90–94. | |
| Hughes WT, Armstrong D, Bodey GP et al. (2002) 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clinical Infectious Diseases 34: 730–751. | |
| Klein C, Grudzien M, Appaswamy G et al. (2007) HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nature Genetics 39: 86–92. | |
| Kuderer NM, Dale DC, Crawford J, Cosler LE and Lyman GH (2006) Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer 106: 2258–2266. | |
| Price TH (2002) Granulocyte transfusion in the G-CSF era. International Journal of Hematology 76(suppl. 2): 77–80. | |
| Rosenberg PS, Alter BP, Link DC et al. (2008) Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropenia. British Journal of Haematology 140: 210–213. | |
| Smith TJ, Khatcheressian J, Lyman GH et al. (2006) 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. Journal of Clinical Oncology 24: 3187–3205. | |
Copyright © 2000-2013 by John Wiley & Sons, Inc., or related companies. All rights reserved.
